Log in Subscribe

In this paper, we selected ER-positive breast cancer MCF-7 cells and used RNA-seq technique to analyze the gene expression differences of Chidamide-treated breast cancer cells to identify the drug targets of Chidamide's anti-breast cancer effect and to l

Langley Avery
· 3 min read
In this paper, we selected ER-positive breast cancer MCF-7 cells and used RNA-seq technique to analyze the gene expression differences of Chidamide-treated breast cancer cells to identify the drug targets of Chidamide's anti-breast cancer effect and to l

The results showed that the MCF-7 CHID group expressed 320 up-regulated genes and 222 down-regulated genes compared to the control group; Gene Ontology functional enrichment analysis showed that most genes were enriched to biological processes. Subsequently, 10 hub genes for Chidamide treatment of breast cancer were identified based on high scores using CytoHubba, a plug-in for Cytoscape: TP53, JUN, CAD, ACLY, IL-6, peroxisome proliferator-activated receptor gamma, THBS1, CXCL8, IMPDH2, and YARS. Finally,  vitamin b2 price  of the Gene Expression Profiling Interactive Analysis database and Kaplan Meier mapper to compare the expression and survival analysis of these 10 hub genes, TP53, ACLY, PPARG, and JUN were found to be potential candidate genes significantly associated with Chidamide for breast cancer treatment. Among them, TP53 may be a potential target gene for Chidamide to overcome multi-drug resistance in breast cancer. Therefore, we identified four genes central to the treatment of breast cancer with Chidamide by bioinformatics analysis, and clarified that TP53 may be a potential target gene for Chidamide to overcome multi-drug resistance in breast cancer. This study lays a solid experimental and theoretical foundation for the treatment of breast cancer at the molecular level with Chidamide and for the commercial or financial relationships that could be construed as a potential among adult survivors of childhood cancer.

BACKGROUND: Over 50% of childhood cancer survivors are exercise intolerant, with maximal aerobic capacities comparable to individuals decades older, suggesting early physiologic ageing. In addition, 36% of survivors are obese. Optimal exercise capacity provides a foundation to support daily function and healthy body habitus and is associated with benefits to cognition, cardiovascular health, and longevity. Cellular senescence and inflammation are key mechanisms that drive age-related disease, quantifiable as biomarkers in peripheral blood. AIMS: This study aimed to evaluate associations between p16(INKa), a biomarker of cellular senescence, and inflammation and exercise capacity among adult survivors of childhood cancer. MATERIALS AND METHODS: Eligible survivors were recruited from the St. Jude Lifetime (SJLIFE) Cohort Study.

Exercise capacity was assessed by maximal oxygen uptake (VO(2), ml/kg/min) obtained via cardiopulmonary exercise testing using a modified Bruce protocol.  vitamin b2 deficiency symptoms  (%) was determined from dual energy x-ray absorptiometry (DEXA). Peripheral blood samples were used to evaluate log(2) p16(INK4a) mRNA expression, a biomarker of cellular senescence, and inflammation with high sensitivity C-reactive protein (hs-CRP) levels. Multivariable regression evaluated associations between p16(INK4a), hs-CRP, body fat, and exercise capacity. RESULTS: Participants included 185 five-year childhood cancer survivors (mean age 6 [range 1 - 7] years, 44% male, 77% non-Hispanic white, 53% leukemia/lymphoma). Compared to males, females had lower peak VO(2) (mean ± SD, 5 ± 2 vs. 8 ± 7 ml/kg/min, p<01), higher p16(INK4a) expression (6 ± 2 vs.

2 ± 2 fold, p=02), and hs-CRP concentration (9 ± 4 vs. 3 ± 9 mg/L, p=01). Among females (n=103), hs-CRP concentration (β -2, 95% CI -34 to -05, p=01) and p16(INK4a) expression (β-32, 95% CI 42 to -22, p=04) were inversely associated and statistically significant with peak exercise capacity, with a significant interaction between p16(INK4a) expression and body fat (β 15, 95% CI 02 to 28, p=03). Among males (n=82), p16(INK4a) expression (β -01, 95% CI -14 to 12, p=08), and body fat (β -54, 95% CI -70 to -38, p<01) were inversely associated with peak exercise capacity. CONCLUSION: Inflammation and p16(INK4a) expression, a biomarker of cellular senescence, are associated with lower exercise capacity in childhood cancer survivors, suggesting potential targets or outcome measures for interventions designed to prevent or remediate accelerated physiologic ageing in this population. commercial or financial relationships that could be construed as a potential People living in developing countries are exposed to hepato-renal injuries induced by heavy metals like lead (Pb), cadmium (Cd), and mercury (Hg) since drinking water supplied is often polluted with a high concentration of those metals. Accordingly, it is necessary to search for antidotes against heavy metals poisoning.

Hence, medicinal plants bearing anti-hepatotoxic properties represent a credible option; and such plant is Khaya grandifoliola. However, there is a paucity of knowledge regarding its protective effect on heavy metals-induced hepato-renal toxicity. Thus, this study was designed to assess the protective effect of the hydro-ethanolic stem bark extract of K. grandifoliola (HKG) against hepato-renal injuries induced by chronic consumption of drinking water containing high contents of Pb, Cd, and Hg; in addition to the investigation of the chemical antioxidant properties of HKG. For the antioxidant assays, HKG was tested as a phosphomolybdenum, and scavenger of hydroxyl and 2,2-Diphenyl-Picryl-Hydrazyl radicals.